BMGL
Basel Medical Group
$4.75
+$0.15 (+3.26%)Oct 29, 2026
Key metrics
The numbers that frame BMGL today
- Market cap
- $7.44M
- Gross margin
- 75.8%
- EV / Sales
- 1.1
- ROIC
- -64.4%
- Div yield
- 0%
- Debt / equity
- 1.4
- 52wk Low
- $2.56
- 52wk High
- $19.20
Growth
Revenue and earnings trend for BMGL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BMGL
Is Basel Medical Group a good buy?
No. Basel Medical Group has poor quality and poor momentum. Both signals point to a weaker setup. We think Basel Medical Group is selling at a very high price.
What is the market capitalization of BMGL?
Basel Medical Group's market capitalization is $7.44M.
What is the 52-week high for BMGL stock?
The 52-week high for Basel Medical Group is $19.20. The current close of $4.75 is 75.3% below that high.
What is the 52-week low for BMGL stock?
The 52-week low for Basel Medical Group is $2.56. The current close of $4.75 is 85.5% above that low.
Does BMGL stock pay dividends?
Basel Medical Group does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BMGL?
Basel Medical Group's Debt / Equity ratio is 1.44.